Can a simple injection predict migraine relief? new study aims to find out
NCT ID NCT07170111
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will follow 460 migraine patients who receive a nerve block injection in the back of the head. Researchers want to find out which patient traits—like migraine type or headache patterns—predict a good response. The goal is to help doctors choose the right treatment for each person.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If successful, this could help doctors identify which migraine patients are most likely to benefit from nerve block injections, making treatment more personalized.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't prove the block works—only what predicts success. Results may not apply to all migraine patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Başakşehir Çam and Sakura City Hospital
Istanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a numbing nose treatment stop migraine pain in its tracks?
- Can migraine meds be safe while breastfeeding? a new study investigates
- Could a symptom registry unmask hidden migraine variants?
- A migraine-blocking antibody tested in children as young as 6
- Mind over migraine: brain network may explain why some expect side effects
- The eyes as a window to the brain: can a simple scan monitor MS, Alzheimer's, and Parkinson's?